L
Lori E. Dodd
Researcher at National Institutes of Health
Publications - 98
Citations - 28495
Lori E. Dodd is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Clinical trial & Medicine. The author has an hindex of 30, co-authored 86 publications receiving 22000 citations. Previous affiliations of Lori E. Dodd include University of Cape Town.
Papers
More filters
Journal ArticleDOI
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
Elizabeth Eisenhauer,P. Therasse,Jan Bogaerts,Lawrence H. Schwartz,Daniel J. Sargent,Robert Ford,Janet Dancey,S. Arbuck,S. Gwyther,Margaret M. Mooney,Larry Rubinstein,Lalitha K. Shankar,Lori E. Dodd,Robert M. Kaplan,Denis Lacombe,Jaap Verweij +15 more
TL;DR: The revised RECIST includes a new imaging appendix with updated recommendations on the optimal anatomical assessment of lesions, and a section on detection of new lesions, including the interpretation of FDG-PET scan assessment is included.
Journal ArticleDOI
The Lung Image Database Consortium (LIDC) and Image Database Resource Initiative (IDRI): a completed reference database of lung nodules on CT scans.
Samuel G. Armato,Geoffrey McLennan,Luc Bidaut,Michael F. McNitt-Gray,Charles R. Meyer,Anthony P. Reeves,Binsheng Zhao,Denise R. Aberle,Claudia I. Henschke,Eric A. Hoffman,Ella A. Kazerooni,Heber MacMahon,Edwin J. R. van Beek,David F. Yankelevitz,Alberto Biancardi,Peyton H. Bland,Matthew S. Brown,Roger Engelmann,Gary E. Laderach,Daniel Max,Richard C. Pais,David Qing,Rachael Y. Roberts,Amanda R. Smith,Adam Starkey,Poonam Batra,Philip Caligiuri,Ali Farooqi,Gregory W. Gladish,C. Matilda Jude,Reginald F. Munden,Iva Petkovska,Leslie E. Quint,Lawrence H. Schwartz,Baskaran Sundaram,Lori E. Dodd,Charles Fenimore,David Gur,Nicholas Petrick,John Freymann,Justin Kirby,Brian Hughes,Alessi Vande Casteele,Sangeeta Gupte,Maha Sallam,Michael D. Heath,Michael Kuhn,Ekta Dharaiya,Richard Burns,David Fryd,Marcos Salganicoff,Vikram Anand,Uri Shreter,Stephen Vastagh,Barbara Y. Croft,Laurence P. Clarke +55 more
TL;DR: The goal of this process was to identify as completely as possible all lung nodules in each CT scan without requiring forced consensus and is expected to provide an essential medical imaging research resource to spur CAD development, validation, and dissemination in clinical practice.
Journal ArticleDOI
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
Andre C. Kalil,Thomas F. Patterson,Aneesh K. Mehta,Kay M. Tomashek,Cameron R. Wolfe,Varduhi Ghazaryan,Vincent C. Marconi,Guillermo M. Ruiz-Palacios,Lanny Hsieh,Susan Kline,Victor F. Tapson,Nicole M. Iovine,Mamta K. Jain,Daniel A. Sweeney,Hana M. El Sahly,Angela Branche,Justino Regalado Pineda,David C. Lye,Uriel Sandkovsky,Anne F Luetkemeyer,Stuart H. Cohen,Robert W. Finberg,Patrick E. H. Jackson,Babafemi Taiwo,Catharine I. Paules,Henry Arguinchona,Nathaniel B. Erdmann,Neera Ahuja,Maria G. Frank,Myoung Don Oh,Eu-Suk Kim,Seow Y Tan,Richard A. Mularski,Henrik Nielsen,Philip O Ponce,Barbara S. Taylor,LuAnn Larson,Nadine Rouphael,Youssef Saklawi,Valeria D Cantos,Emily R Ko,John J. Engemann,Alpesh Amin,Miki Watanabe,Joanne Billings,Marie-Carmelle Elie,Richard T. Davey,Timothy Burgess,Jennifer Ferreira,Michelle Green,Mat Makowski,Anabela Cardoso,Stephanie de Bono,Tyler Bonnett,Michael A. Proschan,Gregory A. Deye,Walla Dempsey,Seema U Nayak,Lori E. Dodd,John H. Beigel +59 more
TL;DR: Baricitinib plus remdesivir was superior to remdes Vivir alone in reducing recovery time and accelerating improvement in clinical status among patients with Covid-19, notably among those receiving high-flow oxygen or noninvasive ventilation.
Journal ArticleDOI
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.
Sabue Mulangu,Lori E. Dodd,Richard T. Davey,Tshiani Mbaya O,Proschan M,Mukadi D,Lusakibanza Manzo M,Didier Nzolo,Tshomba Oloma A,Ibanda A,Ali R,Sheick Oumar Coulibaly,Adam C. Levine,Rebecca F. Grais,Diaz J,H C Lane,Muyembe-Tamfum Jj,Sivahera B,Camara M,Kojan R,Walker R,Bonnie Dighero-Kemp,Huyen Cao,Mukumbayi P,Mbala-Kingebeni P,Ahuka S,Albert S,Tyler Bonnett,Ian Crozier,Duvenhage M,Proffitt C,Teitelbaum M,Moench T,Aboulhab J,Kevin Barrett,Cahill K,Cone K,Eckes R,Lisa E. Hensley,Herpin B,Elizabeth S. Higgs,Ledgerwood J,Pierson J,Smolskis M,Sow Y,Tierney J,Sivapalasingam S,Holman W,Gettinger N,Vallée D,Nordwall J +50 more
TL;DR: A shorter duration of symptoms before admission and lower baseline values for viral load and for serum creatinine and aminotransferase levels each correlated with improved survival, and both MAb114 and REGN-EB3 were superior to ZMapp in reducing mortality from EVD.
Journal ArticleDOI
Partial AUC estimation and regression.
Lori E. Dodd,Margaret S. Pepe +1 more
TL;DR: The regression framework is described, which is used to compare two prostate‐specific antigen biomarkers and to evaluate the dependence of biomarker accuracy on the time prior to clinical diagnosis of prostate cancer.